Congenital heart disease: the original heart failure syndrome.

[1]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[2]  S. Anker,et al.  Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease , 2002, Circulation.

[3]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[4]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[5]  Peter P Karpawich,et al.  Collaborative care for adults with congenital heart disease. , 2002, Circulation.

[6]  B. Meibohm,et al.  Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters. , 2002, American heart journal.

[7]  E. Foster,et al.  Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. , 2001, The American journal of cardiology.

[8]  S. Anker,et al.  High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. , 2001, Cytokine.

[9]  E. E. van der Wall,et al.  Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction , 2001, Heart.

[10]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[11]  J J O'Sullivan,et al.  Survival with congenital heart disease and need for follow up in adult life , 2001, Heart.

[12]  Geoffrey I. Webb,et al.  Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. , 2001, The American journal of cardiology.

[13]  Geoffrey I. Webb,et al.  Aerobic capacity in adults with various congenital heart diseases. , 2001, The American journal of cardiology.

[14]  W. Williams,et al.  What is the Optimal Age for Repair of Tetralogy of Fallot? , 2000, Circulation.

[15]  S. Siu,et al.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study , 2000, The Lancet.

[16]  T. McDonagh.  Asymptomatic left ventricular dysfunction in the community , 2000, Current cardiology reports.

[17]  T. Iivainen,et al.  Serum N‐terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect , 2000, European journal of heart failure.

[18]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[19]  Simon Stewart,et al.  Epidemiology, aetiology, and prognosis of heart failure , 2000, Heart.

[20]  O. K. Hansen,et al.  Neurohormonal activation late after cavopulmonary connection , 2000, Heart.

[21]  C. Frampton,et al.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.

[22]  L. Hillis,et al.  Congenital heart disease in adults: First of two parts , 2000 .

[23]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[24]  D. Mann.  Mechanisms and models in heart failure: A combinatorial approach. , 1999, Circulation.

[25]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[26]  S. Gidding,et al.  Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[28]  R. Shaddy,et al.  Beta-blocker therapy in young children with congestive heart failure under consideration for heart transplantation. , 1998, American heart journal.

[29]  M. Metra,et al.  Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure. , 1998, European heart journal.

[30]  Wiklund Ra,et al.  First of two parts , 1997 .

[31]  C. Hall,et al.  Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease. , 1997, Circulation.

[32]  P. Poole‐Wilson,et al.  Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. , 1997, Journal of the American College of Cardiology.

[33]  M. Komajda,et al.  Prognostic value of plasma endothelin-1 in patients with chronic heart failure. , 1997, European heart journal.

[34]  A. Coats,et al.  The "muscle hypothesis" of chronic heart failure. , 1996, Journal of molecular and cellular cardiology.

[35]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[36]  D. Kelly,et al.  Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease. , 1996, The American journal of cardiology.

[37]  S. Ishikawa,et al.  Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair. , 1995, The Journal of thoracic and cardiovascular surgery.

[38]  A. Coats,et al.  The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure. , 1994, Circulation.

[39]  V. Fuster,et al.  Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. , 1993, The New England journal of medicine.

[40]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[41]  M. Packer.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.

[42]  K. Nakao,et al.  Plasma Endothelin Concentrations in Patients With Pulmonary Hypertension Associated With Congenital Heart Defects: Evidence for Increased Production of Endothelin in Pulmonary Circulation , 1991, Circulation.

[43]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[44]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[45]  S. Gottlieb,et al.  Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. , 1989, Journal of the American College of Cardiology.

[46]  S. Daniels,et al.  Return of plasma norepinephrine to normal after resolution of congestive heart failure in congenital heart disease. , 1987, The American journal of cardiology.

[47]  M. Diver,et al.  Plasma renin activity in infants with congenital heart disease. , 1987, Archives of disease in childhood.

[48]  B. Whipp,et al.  Dynamics of oxygen uptake during exercise in adults with cyanotic congenital heart disease. , 1986, Circulation.

[49]  S. Bloom,et al.  Alpha atrial natriuretic peptide concentrations in plasma in children with congenital heart and pulmonary diseases. , 1985, British medical journal.

[50]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[51]  S. C. Mitchell,et al.  Etiologic correlates in a study of congenital heart disease in 56,109 births. , 1971, The American journal of cardiology.

[52]  S. Korones,et al.  Congenital Heart Disease in 56,109 Births Incidence and Natural History , 1971, Circulation.

[53]  J. Ochsner,et al.  Congenital Heart Disease in Adults , 1967, Southern medical journal.

[54]  M. Lees.  Catecholamine metabolite excretion of infants with heart failure. , 1966, The Journal of pediatrics.

[55]  吉林 宗夫.  Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects : evidence for increased production of endothelin in pulmonary circulation , 1992 .

[56]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.